_{Product Name:Fluvoxamine Maleate
Synonyms:FLUVOXAMINE MALEATE
CAS:61718-82-9
MF:C19H25F3N2O6
MW:434.41
EINECS:228-994-3
Product Categories:Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Serotonin receptor
Melting point:120-121.5 °C
Fp:9ºC
Storage temp.: 2-8°C
Chemical Properties:White Crystalline Powders
Uses:A selective serotonin reuptake inhibitor (SSRI) used as an anti-depressant. Antiobsessional.
Uses:estrogen .Depression, obsessive-compulsive disorder treatment
Uses: nonsteroidal anti-inflammatory reduces pain and inflammation in eyes.
Uses: Anxiety disorder.}

_{Depression is recommended starting dose of 50 mg or 100 mg daily, taken once night. Increment gradually until effective. Commonly used effective dose of 100 mg per day, and can be adjusted according to personal response. Individual cases can be increased to 300 mg daily. If the daily dose of more than 150 mg, can be divided into several doses. WHO requires the patient to continue taking antidepressants for at least 6 months after symptom relief. The drug used to prevent the recurrence of depression recommended dose of 100 mg daily. Obsessive-compulsive disorder is recommended starting dose of 50 mg daily for 3-4 days, usually in an effective dose of 100-300 mg daily. Should be gradually increased until the effective dose is reached. The daily maximum dose for adults is 300 mg, and the daily maximum dose for children and adolescents over 8 years old is 200 mg. A single oral dose can be increased to 150 mg daily, before going to bed. If the daily dose of more than 150 mg, can be divided 2-3 times service.
If you have obtained a good therapeutic effect, you can continue to use this based on personal response to adjust the dose. If the medication did not improve the symptoms within 10 weeks should continue to use this product. Although there is no systematic data that suggests the maximum duration of fluvoxamine therapy, treatment may be greater than 10 weeks because obsessive-compulsive disorder is a chronic condition. Carefully adjust the dose according to the patient's condition so that the patient receives the lowest possible effective dose. And should regularly evaluate whether to continue treatment. Can also consider the use of behavioral therapy .}